Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G SCHWARTZ

Showing results (101-110 of 1,353) with videos related to

Pageof 136
Sort By:
Current Pharmaceutical Design|February 2, 2019
Current and Future Pharmacologic Therapies for Diabetic RetinopathyVictor M Villegas, Stephen G Schwartz
Clinical Parkinsonism & Related Disorders|December 20, 2021
Lead service lines and Parkinson's disease prevalence in U.S. StatesGary G Schwartz, Mark R Williamson
Clinical Orthopaedics and Related Research|November 1, 1984
Juvenile nodular aponeurotic fibroma in the area of the knee jointH Aprin, G Schwartz, S Lipper
Journal of Speech and Hearing Research|June 1, 1992
Converging evidence for underlying phonological representation in a child who misarticulatesK K McGregor, R G Schwartz
Atherosclerosis|May 23, 2022
Existing and emerging strategies to lower Lipoprotein(a)Gregory G Schwartz, Christie M Ballantyne
Cancer|December 15, 1992
Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiationC L Hanchette, G G Schwartz
Journal of Environmental Radioactivity|June 9, 2018
Radon and lung cancer: What does the public really know?Nancy Vogeltanz-Holm, Gary G Schwartz
Case Reports in Cardiology|May 16, 2019
Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion ImagingSohab S Radwan, Owen G Schwartz
Cancer Letters|May 23, 2001
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomesA G Schwartz, L L Pashko
Current Pharmaceutical Biotechnology|October 14, 2010
Fluocinolone acetonide implantable device for diabetic retinopathyStephen G Schwartz, Harry W Flynn
Pageof 136

Showing results (101-110 of 1,353) with videos related to

Sort By:
Pageof 136
Current Pharmaceutical Design|February 2, 2019
Current and Future Pharmacologic Therapies for Diabetic RetinopathyVictor M Villegas, Stephen G Schwartz
Clinical Parkinsonism & Related Disorders|December 20, 2021
Lead service lines and Parkinson's disease prevalence in U.S. StatesGary G Schwartz, Mark R Williamson
Clinical Orthopaedics and Related Research|November 1, 1984
Juvenile nodular aponeurotic fibroma in the area of the knee jointH Aprin, G Schwartz, S Lipper
Journal of Speech and Hearing Research|June 1, 1992
Converging evidence for underlying phonological representation in a child who misarticulatesK K McGregor, R G Schwartz
Atherosclerosis|May 23, 2022
Existing and emerging strategies to lower Lipoprotein(a)Gregory G Schwartz, Christie M Ballantyne
Cancer|December 15, 1992
Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiationC L Hanchette, G G Schwartz
Journal of Environmental Radioactivity|June 9, 2018
Radon and lung cancer: What does the public really know?Nancy Vogeltanz-Holm, Gary G Schwartz
Case Reports in Cardiology|May 16, 2019
Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion ImagingSohab S Radwan, Owen G Schwartz
Cancer Letters|May 23, 2001
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomesA G Schwartz, L L Pashko
Current Pharmaceutical Biotechnology|October 14, 2010
Fluocinolone acetonide implantable device for diabetic retinopathyStephen G Schwartz, Harry W Flynn
Pageof 136